NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£154M
Sector
HEALTH
Published
11 Aug 2022
Delivery
01 Sep 2022 to 31 Aug 2024
Deadline
12 Apr 2022 13:00

Concepts

Location

Geochart for 1 buyers and 28 suppliers

1 buyer

28 suppliers

Description

NHS London Branded Medicines - Tranche A and Annual Offer reference number: CM/PHR/20/5614 CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Award Detail

1 Merck Sharpe & Dohme (London)
  • Value: £153,778,681
2 Almirall (Uxbridge)
  • Value: £153,778,681
3 Vifor Pharma (London)
  • Value: £153,778,681
4 Amgen (Cambridge)
  • Value: £153,778,681
5 Abbvie (Maidenhead)
  • Value: £153,778,681
6 Celltrion Healthcare (Slough)
  • Value: £153,778,681
7 Sobi Swedish Orphan Biovitrum (Great Abington)
  • Value: £153,778,681
8 Ipsen (Slough)
  • Value: £153,778,681
9 Astrazeneca (London)
  • Value: £153,778,681
10 Thornton & Ross (Huddersfield)
  • Value: £153,778,681
11 Pfizer (None)
  • Value: £153,778,681
12 Glaxosmithkline (London)
  • Value: £153,778,681
13 Merz (Hemel Hamstead)
  • Value: £153,778,681
14 Accord (Barnstaple)
  • Value: £153,778,681
15 Teva (Castleford)
  • Value: £153,778,681
16 Zentiva Pharma (London)
  • Value: £153,778,681
17 Merck Serono (None)
  • Value: £153,778,681
18 Takeda (London)
  • Value: £153,778,681
19 Aventis Pharma (Reading)
  • Value: £153,778,681
20 Sandoz (None)
  • Value: £153,778,681
21 Eli Lilly (Basingstoke)
  • Value: £153,778,681
22 Roche Products (Welwyn Garden City)
  • Value: £153,778,681
23 Janssen Cilag (Highwycombe)
  • Value: £153,778,681
24 Pharmacosmos (Reading)
  • Value: £153,778,681
25 Ucb Pharma (None)
  • Value: £153,778,681
26 Novo Nordisk (Gatwick)
  • Value: £153,778,681
27 Gedeon Richter (London)
  • Value: £153,778,681
28 Organon Pharmaceuticals (London)
  • Value: £153,778,681

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Document No. 03 - Framework Agreement and Terms and Conditions (3) Document No. 03 - Framework Agreement and Terms and Conditions (3).docx 220307 - FTS-004234 _ Salesforce - Enterprise Edition V2 220307 - FTS-004234 _ Salesforce - Enterprise Edition V2.pdf 220726 - Appendix 2 To Framework Agreement - TRANSPARENCY Award Schedule - CMPHR20561401 London Proprietary 220726 - Appendix 2 To Framework Agreement - TRANSPARENCY Award Schedule - CMPHR20561401 London Proprietary.pdf 220726 - Appendix 2 To Framework Agreement - TRANSPARENCY Award Schedule - CMPHR20561402 London Proprietary 220726 - Appendix 2 To Framework Agreement - TRANSPARENCY Award Schedule - CMPHR20561402 London Proprietary.pdf Document No. 10 - Participating Authorities (2) Document No. 10 - Participating Authorities (2).xls Parties Appointed to the Framework Agreement - CMPHR205614 Branded - NHS London Branded Medicines - Tranche A - September 2022 Parties Appointed to the Framework Agreement - CMPHR205614 Branded - NHS London Branded Medicines - Tranche A - September 2022.xlsx

Reference

Domains